Search results

151. Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disord…

Principal investigator: Michał Kamiński

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

152. Can positronium lifetime reveal chemical modifications in biological samples?

Principal investigator: Simbarashe Moyo

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

153. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat…

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

Call: OPUS 29, Panel: NZ7

154. Cardiotoxicity of Anthracyclines – The Influence of Metal Ions on the Properties of Annamycin and Doxorubicin

Principal investigator: prof. Włodzimierz Wiktor Lewandowski

POLITECHNIKA BIAŁOSTOCKA

Call: OPUS 29, Panel: NZ7

155. Non-coding RNAs to diagnose developing myocardial infarction – a prospective study using next-generation sequencing.

Principal investigator: Ewelina Błażejowska

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM 24, Panel: NZ7

156. The JAK/STAT pathway as a molecular contributor to the development of endometriosis: therapeutic potential of JAK inhibi…

Principal investigator: Aleksander Radosław Rycerz

Uniwersytet Medyczny w Łodzi

Call: PRELUDIUM 24, Panel: NZ7

157. Metabolic biomarkers of prostate cancer

Principal investigator: prof. Tomasz Łukasz Ruman

Politechnika Rzeszowska im. Ignacego Łukasiewicza

Call: OPUS 29, Panel: NZ7

158. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir…

Principal investigator: prof. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 29, Panel: NZ7

159. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

160. Novel covalent modulators of plasma kallikrein activity

Principal investigator: Jan Konopka

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

161. suPAR in older adults – a new biomarker of inflammageing, sarcopenia, and malnutrition?

Principal investigator: Karolina Agnieszka Dzięcioł

Uniwersytet Medyczny w Łodzi

Call: PRELUDIUM 24, Panel: NZ7

162. The role of the ABCA1 protein in cholesterol metabolism and the organization of key cell membrane structures in the proc…

Principal investigator: Aleksandra Mordzińska-Rak

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 24, Panel: NZ7

163. Neurotoxicity of nanoplastics - searching for the possible link between exposure to nanoplastics and neurodegenerative d…

Principal investigator: prof. Lidia Marta Strużyńska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 29, Panel: NZ7

164. PFAS from Tap to Table: Does Contaminated Water Intensify Food Contamination During Cooking?

Principal investigator: dr hab. Szczepan Tomasz Mikołajczyk

Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy

Call: OPUS 29, Panel: NZ7

165. Multifunctional polymer-based scaffold incorporating green synthesized nanocomposite and silibinin for liver regeneratio…

Principal investigator: dr Barbara Agnieszka Strojny-Cieślak

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

Call: OPUS 29, Panel: NZ7

166. Targeting endothelial cell senescence in diabetic retinopathy with rapamycin-loaded nanoparticles

Principal investigator: Gabriela Burda

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

167. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep…

Principal investigator: Magdalena Anna Nowak

Politechnika Opolska

Call: PRELUDIUM 24, Panel: NZ7

168. Mini-tumors, big answers: Modeling of immune system's activation with organoid-based PDT-on-Chip technology

Principal investigator: Marta Karolina Warszyńska

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

169. Building cognitive and brain reserve: the trajectory of protective and risk factors in a longitudinal cohort study of th…

Principal investigator: prof. Katarzyna Zatońska

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: OPUS 29, Panel: NZ7

170. Cholesin and its receptor as novel therapeutic and diagnostic targets in metabolic disorders

Principal investigator: prof. Wojciech Fendler

Uniwersytet Medyczny w Łodzi

Call: OPUS 29, Panel: NZ7

171. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh…

Principal investigator: Katarzyna Aleksandra Szafrańska

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

172. The Enigma of the Estrobolome: Microbial Engineering of Human Estrogen Metabolism

Principal investigator: prof. Grażyna Jasieńska

Uniwersytet Jagielloński

Call: OPUS 29, Panel: NZ7

173. PREMILK - Preeclampsia-Related Metabolomic Insights into Lactation and Nutrition in Premature Infants

Principal investigator: Ewa Magdalena Sokołowska

Gdański Uniwersytet Medyczny

Call: PRELUDIUM 24, Panel: NZ7

174. Structural and Biocompatibility Aspects of Duo-gels: Fundamental Research on the Integration of Hydrophobic and Hydrophi…

Principal investigator: Alicja Przybyłowicz

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: PRELUDIUM 24, Panel: NZ7

175. Photodynamic inactivation as a broad-spectrum antibiotic adjuvant reversing multidrug-resistant Gram-negative critical p…

Principal investigator: dr hab. Mariusz Stanisław Grinholc

Uniwersytet Gdański

Call: OPUS 29, Panel: NZ7

176. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

Principal investigator: Arkadiusz Bogumił Leniak

Instytut Farmakologii PAN

Call: PRELUDIUM 24, Panel: NZ7

177. Unravelling the Mechanisms of Streptococcus agalactiae Tolerance to Oxidative Stress as the Key to Developing Modern The…

Principal investigator: dr Michał Karol Pierański

Politechnika Gdańska

Call: SONATINA 9, Panel: NZ7

178. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

Principal investigator: dr Daniel Ryszard Ziental

Uniwersytet Przyrodniczy w Poznaniu

Call: SONATINA 9, Panel: NZ7

179. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d…

Principal investigator: dr Krzysztof Bartnik

Politechnika Warszawska

Call: SONATINA 9, Panel: NZ7

180. Advanced High-Throughput Microfluidic Platform for Engineered T-Cell Screening

Principal investigator: dr Alicja Andrea Przybyszewska-Podstawka

Uniwersytet Warszawski

Call: SONATINA 9, Panel: NZ7

181. Role of the sinonasal microbiota in modulating airway immunity and allergic inflammation

Principal investigator: dr hab. Sabina Barbara Górska

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: OPUS 28 (LAP), Panel: NZ7

182. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu…

Principal investigator: dr hab. Ewelina Piktel

Uniwersytet Medyczny w Białymstoku

Call: SONATA 20, Panel: NZ7

183. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

Principal investigator: dr Joanna Dagmara Fedorowicz

Gdański Uniwersytet Medyczny

Call: SONATA 20, Panel: NZ7

184. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif…

Principal investigator: prof. Małgorzata Kajta

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

185. Investigating the properties of 3d–printed polymeric membranes as personalized dressings for hard-to-heal wounds.

Principal investigator: dr Ewelina Zofia Baran

Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

Call: SONATA 20, Panel: NZ7

186. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

187. The influence of beta2-receptor N-terminal polymorphismsadrenergic on its functionality, interactions withdrugs and the …

Principal investigator: dr hab. Anita Elżbieta Płazińska

Uniwersytet Medyczny w Lublinie

Call: OPUS 28, Panel: NZ7

188. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t…

Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 20, Panel: NZ7

189. In vitro cultures of Trifolium rubens L. – phytochemical, biotechnological studies and evaluation of biological activity

Principal investigator: dr Marta Karolina Klimek-Szczykutowicz

Uniwersytet Jana Kochanowskiego w Kielcach

Call: SONATA 20, Panel: NZ7

190. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

Principal investigator: dr Jacek Plewka

Uniwersytet Jagielloński

Call: SONATA 20, Panel: NZ7

191. The role of oral vitamin C supplementation in the epigenetic regulation of male fertility - finding the missing puzzles

Principal investigator: dr hab. Monika Frączek

Instytut Genetyki Człowieka PAN

Call: OPUS 28, Panel: NZ7

192. Investigating the barriers and facilitators to emergency department use among refugees from Ukraine in Poland (EDURef)

Principal investigator: dr Iwona Anna Bielska

Uniwersytet Jagielloński

Call: OPUS 28, Panel: NZ7

193. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

Principal investigator: dr Natalia Anna Maciejewska

Politechnika Gdańska

Call: OPUS 28, Panel: NZ7

194. Defining The Role of Microbiome Mimicry in Type 1 Diabetes (T1D): a pilot study for Single-Cell Strain-characterisation …

Principal investigator: dr Marcin Lukasz Pekalski

Wojskowy Instytut Medyczny

Call: OPUS 28, Panel: NZ7

195. Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple …

Principal investigator: prof. Bogusław Bronisław Machaliński

Pomorski Uniwersytet Medyczny w Szczecinie

Call: OPUS 28, Panel: NZ7

196. Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende…

Principal investigator: dr Hanna Kletkiewicz

Uniwersytet Mikołaja Kopernika

Call: SONATA 20, Panel: NZ7

197. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

Principal investigator: dr hab. Tomasz Piotr Rygiel

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 28, Panel: NZ7

198. Decoding the novel role of the histamine H3 receptor in opioid-induced analgesia and hyperalgesia: studies toward innova…

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

199. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

Principal investigator: dr hab. Ewa Taracha

Instytut Psychiatrii i Neurologii

Call: OPUS 28, Panel: NZ7

200. Light Against Darkness: Biocompatible Photoactivated Pharmaceuticals for Combating Multidrug Resistant Bacterial Infecti…

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński

Call: OPUS 28, Panel: NZ7

Projects search